Cargando…

Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation

NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabaña-Brunod, Mauricio, Herrera, Pablo A., Márquez-Miranda, Valeria, Llancalahuen, Felipe M., Duarte, Yorley, González-Nilo, Danilo, Fuentes, Juan A., Vilos, Cristián, Velásquez, Luis, Otero, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174487/
https://www.ncbi.nlm.nih.gov/pubmed/34060399
http://dx.doi.org/10.1080/10717544.2021.1923862
_version_ 1783702920257077248
author Cabaña-Brunod, Mauricio
Herrera, Pablo A.
Márquez-Miranda, Valeria
Llancalahuen, Felipe M.
Duarte, Yorley
González-Nilo, Danilo
Fuentes, Juan A.
Vilos, Cristián
Velásquez, Luis
Otero, Carolina
author_facet Cabaña-Brunod, Mauricio
Herrera, Pablo A.
Márquez-Miranda, Valeria
Llancalahuen, Felipe M.
Duarte, Yorley
González-Nilo, Danilo
Fuentes, Juan A.
Vilos, Cristián
Velásquez, Luis
Otero, Carolina
author_sort Cabaña-Brunod, Mauricio
collection PubMed
description NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. To develop a nanocarrier capable of achieving a high and prolonged activation over time, iE-DAP was encapsulated in nanoparticles (NPs) made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). The physicochemical properties, colloidal stability, encapsulation efficiency, and cellular uptake of iE-DAP-loaded PHVB NPs were analyzed. Results evidenced that physicochemical properties of iE-DAP-loaded NPs remained stable over time, and NPs were efficiently internalized into cells, a process that depends on time and concentration. Moreover, our results showed that NPs elicited a controlled cargo release in vitro, and the encapsulated agonist response was higher than its free form, suggesting the possibility of activating intracellular receptors triggering an immune response through the release of NOD1 agonist.
format Online
Article
Text
id pubmed-8174487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-81744872021-06-10 Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation Cabaña-Brunod, Mauricio Herrera, Pablo A. Márquez-Miranda, Valeria Llancalahuen, Felipe M. Duarte, Yorley González-Nilo, Danilo Fuentes, Juan A. Vilos, Cristián Velásquez, Luis Otero, Carolina Drug Deliv Research Article NOD1 is an intracellular receptor that, when activated, induces gene expression of pro-inflammatory factors promoting macrophages and neutrophils recruitment at the infection site. However, iE-DAP, the dipeptide agonist that promotes this receptor's activation, cannot permeate cell membranes. To develop a nanocarrier capable of achieving a high and prolonged activation over time, iE-DAP was encapsulated in nanoparticles (NPs) made of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). The physicochemical properties, colloidal stability, encapsulation efficiency, and cellular uptake of iE-DAP-loaded PHVB NPs were analyzed. Results evidenced that physicochemical properties of iE-DAP-loaded NPs remained stable over time, and NPs were efficiently internalized into cells, a process that depends on time and concentration. Moreover, our results showed that NPs elicited a controlled cargo release in vitro, and the encapsulated agonist response was higher than its free form, suggesting the possibility of activating intracellular receptors triggering an immune response through the release of NOD1 agonist. Taylor & Francis 2021-06-01 /pmc/articles/PMC8174487/ /pubmed/34060399 http://dx.doi.org/10.1080/10717544.2021.1923862 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cabaña-Brunod, Mauricio
Herrera, Pablo A.
Márquez-Miranda, Valeria
Llancalahuen, Felipe M.
Duarte, Yorley
González-Nilo, Danilo
Fuentes, Juan A.
Vilos, Cristián
Velásquez, Luis
Otero, Carolina
Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
title Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
title_full Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
title_fullStr Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
title_full_unstemmed Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
title_short Development of a PHBV nanoparticle as a peptide vehicle for NOD1 activation
title_sort development of a phbv nanoparticle as a peptide vehicle for nod1 activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174487/
https://www.ncbi.nlm.nih.gov/pubmed/34060399
http://dx.doi.org/10.1080/10717544.2021.1923862
work_keys_str_mv AT cabanabrunodmauricio developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT herrerapabloa developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT marquezmirandavaleria developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT llancalahuenfelipem developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT duarteyorley developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT gonzaleznilodanilo developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT fuentesjuana developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT viloscristian developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT velasquezluis developmentofaphbvnanoparticleasapeptidevehiclefornod1activation
AT oterocarolina developmentofaphbvnanoparticleasapeptidevehiclefornod1activation